Contacts: Anthony G. Viscogliosi, (212) 583-9700 ext. 100
Nick Kilsby, Creative Partners PR, (203) 705-9202
MORE THAN 1,000 SURGEONS REGISTER TO ATTEND
SBi WORKSHOPS AT NEXT WEEK’S AMERICAN SOCIETY FOR SURGERY OF THE
NEW YORK, NY- September 17, 2007 - Small
Bone Innovations, Inc. (SBi), a single source provider of products,
technology and education for treating small bones and joints, reports
that more than 1,000 hand surgeons have registered to attend eight workshops
funded by SBi during the 62nd Annual Meeting of the American Society
for Surgery of the Hand (ASSH) to be held in Seattle from September
26 through September 29, 2007.
The conference in Seattle’s Washington State Convention &
Trade Center is expected to attract more than 2,000 surgeons and several
thousand orthopedics industry representatives from 36 nations involved
in the treatment of the millions who annually, due to accidents, birth
defects or diseases such as arthritis, require treatment in the upper
“For people like me, the ASSH conference is an opportunity to
present ‘first hand’ our latest technology and give surgeons
the chance to practice a variety of procedures under the guidance of
some of the nation’s best known hand surgeons,” said Anthony
G. Viscogliosi, Chairman and CEO of SBi. “Although this is only
our third ASSH convention, we are honored to be the exclusive ‘Platinum’
sponsor of the event - especially the workshops for which more than
half of all surgeons attending have registered – in addition to
having SBi products featured in many of the CME (continuing medical
education) sessions,” he added.
SBi will also host a meeting of the ASSH Young Leaders Group that comprises
60 surgeons selected by the society to work together and share experiences
in the advancement of hand surgery. The group’s meetings have
been supported by SBi since inception in 2005.
SBi is launching ten new products at ASSH to augment its Elbow Management
System; Artelon© spacer suite for treating osteoarthritis in the
thumb; the SBi Wrist portfolio; and its ‘FIX’ range of foot
& ankle fixation and arthroplasty products. The new products are
central to SBi’s goal of developing the industry’s widest
and deepest, anatomically focused portfolio.
According to SBi, out of more than 460 ‘podium talks’ at
the ASSH convention, 126 will address arthroplasty, tissue technology
and trauma of which 49 will be based on the use of SBi devices. The
company will also be responsible for four poster exhibits at the event.
The dates, content and faculty of the eight workshops sponsored by SBi
are as follows:
Wednesday, September 26, 2007 5:00 –
Fixed Angle and Fracture Specific Plating for Simple to Complex
Distal Radius Fractures
Jesse B. Jupiter, MD, Boston, MA
David C. Ring, MD, Boston, MA
Three innovative different distal radius systems will be presented,
highlighting the strengths of each for treating various simple and complex
fracture patterns including low profile variable angle locking distal
volar plating, fixed angle distal volar and dorsal plating, and fragment
specific plating solutions.
Presenting a Surgical Implant Algorithmic Approach for Osteoarthritis
of the CMC Joint
Alejandro Badia, MD, Miami, FL
Osteoarthritis of the CMC joint can be treated in a number of ways.
The faculty will present an algorithmic approach for treating the osteoarthritic
joint with various implant options based on disease stage including
early results and technique of Arthroscopic interpositional spacers
and long term results of total joint replacement.
Thursday, September 27, 2007 11:45 AM
– 12:45 PM
New Instrumentation for a Minimal Resection Anatomic Total
William P. Cooney, MD, Vero Beach, FL
Amit Gupta, MD, Louisville, KY
Reproducible positive results with total wrist arthroplasty rely heavily
on the instrumentation and surgical technique. An anatomic wrist instrumentation
system (and implant) will be presented, focusing on minimal bone resection
and consistent results. Medium Term results of the SBi Total Wrist Arthroplasty
system will be reviewed along with discussion on the ongoing Wrist Registry.
Treatment of Thumb CMC Arthritis
Sanjay S. Desai, MD, Richmond, VA
Randall W. Culp, MD, King of Prussia, PA
A number of different methods can be successfully used for treatment
of osteoarthritis of the CMC joint. This workshop will focus on strategies
for the use of a minimally invasive approach to treat earlier stage
OA utilizing a biodegradable resurfacing implant including medium term
Friday, September 28, 2007 11:45 AM – 12:45
Solution to DRUJ Pain, Repair vs. Remove
Sanjay S. Desai, MD, Richmond, VA
Richard A. Berger, MD, PhD, Rochester, MN
Sigmoid Notch prosthesis, in conjunction with ulnar head replacement,
offers an anatomic solution for the restoration of kinematics and stability
for primary DRUJ treatment and salvage. This presentation will explore
the early outcomes of a true anatomic total DRUJ replacement.
Surgical Technique and Short Term Results for the Radio
Capitellum Resurfacing Procedure
William P. Cooney, MD, Vero Beach, FL
The SBi Uni-Elbow™ Radio Capitellum System is designed specifically
for uni-compartmental arthroplasty for degenerative joint diseases,
the correction of functional deformities, revision procedures and treatment
of fractures. This presentation will discuss the indications, implantation
and early results of the first uni-compartmental elbow replacement system.
Saturday, September 29, 2007 6:45 AM – 7:45 AM
Radial Head Fractures, ORIF vs Radial Head Implant Arthoplasty
Douglas P. Hanel, MD, Seattle, WA
Nader Paksima, DO, MPH, New York, NY
Various technologies and techniques for treating radial head fractures
will be presented in an algorithmic approach. This workshop will review
the signs of a salvageable radial head and that of a necessary replacement.
A complete elbow management system will be explored that offers a complete
set of solutions for elbow trauma.
Long Term Outcomes of PIP/MCP Arthroplasty
Kevin J. Renfree, MD, Phoenix, AZ
Peter M. Murray, MD, Jacksonville, FL
Proximal Interphalangeal/Metacarpalphalangeal joint arthroplasty is
known to be an effective method of relieving pain while preserving motion
in the damaged joints. The PIP and MCP joints can be successfully replaced
with a variety of implants and approaches including dorsal, lateral
For a detailed schedule of workshops or for more information on the
ASSH conference, please visit: www.assh.org.
Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi
Bros., LLC, (VB), the New York-based merchant banking firm that specializes
in the musculoskeletal/orthopedic sector. VB created SBi as the first
company to focus purely on small bone & joint science. By integrating
established companies and professionals in the field, SBi can offer
a broad, clinically proven portfolio of products and technologies to
treat trauma and diseases in small bones & joints. Today, SBi has
more than 140 employees at facilities in New York, NY, Morrisville,
PA and Minneapolis, MN.
SBi closed on the sale of $42.2 million
of its securities in December 2005. At the time, based on data provided
by Venture Source, this was the largest venture capital investment
ever recorded in the field of orthopedic devices..
SBi was a 2006 recipient of Red Herring magazine’s
annual “Red Herring 100 North America” award,
recognizing SBi as one of the nation’s leading technology companies
and the only orthopedic device company selected among an initial entry
of more than one thousand firms.
Medical Device & Diagnostic Industry magazine named SBi
to its list of “50 Companies to Watch” in 2006, noting, “Small
Bone Innovations is going against the grain in its determination to become
a market leader in the small bone & joint device sector.”
Additionally, SBi’s Artelon® CMC-I Spacer, developed for patients
with osteoarthritis at the base of the thumb, was featured on the cover and highlighted
within Medical Design Technology magazine’s “Year of Innovation” issue
as one of the most fascinating technologies influencing the medical device industry.
For more information on SBi, please visit: www.totalsmallbone.com
Viscogliosi Bros., LLC
by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi
in New York City in 1999, Viscogliosi Bros., LLC (VB) was the first
venture capital/private equity and merchant banking firm dedicated to
the musculoskeletal/orthopedics sector of the health care industry.
Today, VB is a leading independent firm with a mission to create, build
and finance companies founded on innovations developed by surgeons and
uniquely focused on "life changing" musculoskeletal/orthopedic
technologies. VB has worldwide surgeon, industry and trade relationships
and significant financial expertise in the musculoskeletal/orthopedic
As principals of VB, the Viscogliosi brothers have a combined total
of nearly half a century of experience analyzing and investing in the
musculoskeletal/orthopedics sector, directing literally billions of
dollars through the orthopedics industry. They have pioneered
innovative financial, strategic and management initiatives for nearly
150 companies in the sector, from start-up, seed and development stage
all the way to exit, while helping thousands of people lead better lives
through the orthopedic and spinal products marketed and sold by the
companies they have assisted in developing and financing.
This press release may contain forward-looking statements as defined
in the U.S. Private Securities Litigation Reform Act of 1995. Readers
are cautioned not to place undue reliance on these forward-looking statements.
Actual results may differ materially from those indicated by these forward-looking
statements as a result of risks and uncertainties impacting the Company's
business including increased competition; the ability of the Company
to expand its operations and to attract and retain qualified professionals;
technological obsolescence; general economic conditions; and other risks.
> Back to Press Releases